What Happens When You Stop Taking CJC-1295?

When you stop taking CJC-1295, growth hormone and IGF-1 levels gradually slide back toward your natural baseline over roughly one to two weeks. Most of the effects people notice on cycle — deeper sleep, faster recovery, mild water retention, and a stronger appetite — fade on about the same timeline. There is no reliable evidence that stopping CJC-1295 permanently shuts down your pituitary or your body's own growth hormone production.

CJC-1295 is a growth hormone-releasing hormone (GHRH) analog sold for research use. It is not FDA-approved for human use in the United States, so the details below come from published research and from what users commonly report.

How CJC-1295 Works and Why Stopping Feels Gradual

CJC-1295 binds to GHRH receptors in the pituitary gland and amplifies your own growth hormone pulses. It does not add growth hormone directly.

The form called CJC-1295 with DAC also attaches to albumin in the bloodstream, which stretches its half-life to roughly six to eight days. That long tail is why effects taper off instead of stopping overnight.

If you are still sorting out what is cjc 1295 peptide, the practical takeaway is simple: the drug borrows your pituitary's normal function, so when it clears, that function is still there.

What Happens in the First Week After Your Last Dose

The first few days are usually the most noticeable. Growth hormone pulses shrink back toward normal, and IGF-1 begins its slow decline.

• Appetite: Hunger typically normalizes. People searching does cjc 1295 make you hungry are usually noticing a real on-cycle appetite increase, and that increase fades within one to two weeks off the peptide.
• Water retention: Puffiness in the hands, face, and ankles is usually the first thing to ease.
• Sleep: Deeper sleep fades gradually. A minority of users report several nights of lighter or more broken sleep.
• Injection sites: Redness, itching, or small lumps disappear within days.
• Blood sugar: If fasting glucose crept up while on cycle, it usually drifts back down as IGF-1 falls.

A true withdrawal syndrome is not expected. CJC-1295 is not a controlled substance, and it does not create the physical dependence associated with opioids or benzodiazepines.

Weeks Two to Four: Returning to Baseline

By two to three weeks, most of the peptide has cleared and IGF-1 sits close to where it started. Recovery between workouts can feel slower, and any extra muscle fullness may soften.

That is a return to your body's set point, not a permanent loss. Body composition results depend far more on training, protein intake, and sleep than on the peptide itself.

Sermorelin, a shorter-acting cousin of CJC-1295, follows the same pattern but faster. What happens when you stop taking sermorelin tends to unfold over days rather than weeks, because sermorelin clears within minutes instead of days.

Time after last dose	What typically changes
0 to 72 hours	Injection-site reactions fade; GH pulses begin to shrink, but albumin-bound peptide is still active
Week 1	Appetite and water retention ease; sleep quality starts drifting back
Weeks 2 to 3	IGF-1 approaches pre-cycle baseline; recovery feels normal again
Weeks 4 and beyond	Most users are fully back to baseline, which labs can confirm

Does Stopping CJC-1295 Permanently Suppress Growth Hormone?

Current evidence does not point to permanent suppression. Unlike testosterone, which can shut down the HPG axis for months, GHRH analogs act on receptors that keep responding to your body's own signals once the drug is gone.

Natural growth hormone production typically returns to its previous level after CJC-1295 clears, and the pituitary is not known to be permanently suppressed by GHRH analogs.

That said, anyone with a pre-existing pituitary condition, low IGF-1, or diabetes should confirm their return to baseline with blood work. IGF-1, fasting glucose, and a basic metabolic panel taken four to six weeks after your last dose give the clearest picture.

CJC-1295 Alone vs. Stacked With Ipamorelin or Sermorelin

CJC-1295 is frequently stacked. Ipamorelin triggers a GH pulse through a different receptor, so combining the two creates a broader release than either one alone.

Sermorelin, by contrast, hits the same GHRH receptor as CJC-1295. That overlap is why people ask can you take cjc-1295 and sermorelin together — stacking two GHRH analogs adds cost and injection burden without much extra pituitary stimulation.

Dosing schedules vary by goal and formulation. Most protocols described in research and by users answer how often do you inject cjc-1295 ipamorelin with once-daily dosing before bed.

Option	Half-life	Typical dosing	What stopping looks like
CJC-1295 with DAC	About 6 to 8 days	Once or twice weekly	Gradual taper over 1 to 2 weeks
CJC-1295 without DAC	About 30 minutes	1 to 3 times daily	Effects end within hours
Ipamorelin	About 2 hours	1 to 3 times daily	Rapid return to baseline
Sermorelin	10 to 20 minutes	Once daily at bedtime	Effects fade within days

How to Come Off CJC-1295 Safely

• No formal taper is required, since CJC-1295 tapers itself as it clears from albumin.
• Expect one to two weeks of fading effects, and give yourself that window before judging how you feel.
• Keep training, protein, and sleep consistent so you can tell peptide effects apart from lifestyle changes.
• Wait four to six weeks after your last injection before testing IGF-1, and compare it with a pre-cycle baseline.
• Talk with a healthcare professional before restarting or stacking, especially if you have diabetes, thyroid disease, or a personal or family history of cancer.

Stopping CJC-1295 is a gradual return to your own hormonal baseline, not a crash or a permanent shutdown. The results that stick are the ones built through training and nutrition, and any new cycle should begin with a conversation with a qualified clinician.

COMMON QUESTIONS

Frequently Asked Questions

How long does CJC-1295 stay in your system after you stop?

CJC-1295 with DAC stays bound to albumin for roughly a week or more, so levels can take one to two weeks to fall back to baseline. The version without DAC clears within hours. Because the peptide is not approved for human use, reliable detection windows in blood or urine are not well established.

Does stopping CJC-1295 cause withdrawal symptoms?

There is no known withdrawal syndrome for CJC-1295, and it is not a controlled substance. Some users report a few days of lighter sleep, lower appetite, or slower recovery as IGF-1 drops. Those are return-to-baseline effects rather than true withdrawal.

Will you lose all your results after you stop taking CJC-1295?

You will lose the peptide's short-term effects on sleep, appetite, and water retention, and IGF-1 returns to its previous level. Muscle and strength changes depend mainly on your training and nutrition, and many of them can be maintained. Talk with a healthcare professional before using or stopping any research peptide.